Global registry for benign prostatic hyperplasia treatments

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This ongoing international registry aims to collect demographic data and clinical outcomes for patients undergoing medical or surgical treatments for benign prostatic hyperplasia (BPH). It seeks to analyze patterns and characteristics of men receiving treatment, assess global practice patterns, and evaluate outcomes following various interventions. By standardizing outcome parameters, the registry will provide valuable real-world data that can inform future research and clinical practices in BPH management.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Primary diagnosis of BPH with LUTS with prescribed medical treatment or surgical intervention

Exclusion Criteria:

* Non-symptomatic BPH
* No treatment prescribed for BPH

Where it's running

• Keck Medicine of USC
  Los Angeles, California, United States Recruiting
• Toronto Western Hospital, University Health Network
  Toronto, Ontario, Canada Recruiting
• McGill University Health Centre
  Montreal, Quebec, Canada Recruiting
• Hospital Dr. Juan Morey La Unión
  La Unión, Chile Recruiting
• Hospital del Trabajador
  Santiago, Chile Recruiting
• The First Affiliated Hospital, Zhejiang University School of Medicine
  Hangzhou, China Recruiting

Study contacts

• Principal investigator: Mihir Desai, MD — University of Southern California
• Study coordinator: Mihir Desai, MD
• Email: mihir.desai@med.usc.edu
• Phone: +1 (323) 865 3700

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Tamsulosin alone vs. tamsulosin with tadalafil for troublesome urinary symptoms from enlarged prostate

  This study tests whether adding tadalafil to tamsulosin helps men with BPH see better urinary symptoms and quality of life, using two tadalafil doses over 12 weeks.

  Recruiting Ain Shams University · Cairo, Cairo Governorate · NCT07722884

• Water Vapor Therapy vs Ejaculation-Sparing Enucleation for Benign Prostatic Hyperplasia

  This study tests whether Water Vapor Thermal Therapy (Rezum) or an ejaculation-sparing enucleation procedure better helps sexually active men with bothersome BPH symptoms.

  Recruiting Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07648888

• Water Vapor Therapy versus Ejaculation-Preserving HoLEP for Benign Prostatic Hyperplasia

  This study compares Rezum water vapor therapy to ejaculation-preserving HoLEP in sexually active men with moderate-to-severe symptoms from BPH to see which preserves ejaculation better while easing urinary symptoms.

  Recruiting Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07648875

• Ejaculation-Preserving Bipolar Prostate Enucleation for BPH

  This randomized trial tests whether a modified ejaculation-preserving bipolar TUEP can maintain ejaculation while still relieving urinary symptoms in sexually active men with BPH who didn’t improve with meds.

  Recruiting Beni-Suef University · Banī Suwayf, Beni Suweif Governorate · NCT07629479

• Registry for assessing treatments of benign prostatic hyperplasia

  This study is collecting information to see how well different treatments for enlarged prostate symptoms work, comparing new options with traditional ones for men aged 18 and older.

  Recruiting Cantonal Hospital of St. Gallen · Sankt Gallen, Canton of St. Gallen · NCT03521648

• Sonablate HIFU Registry for Prostate Cancer and BPH

  This registry collects real-world data from men treated with Sonablate HIFU to see how well it works and how it affects urinary and sexual function over the long term.

  Recruiting Sonablate · Indianapolis, Indiana · NCT07757490

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.